FMR1 and fragile X syndrome: All these data confirm a deficit in cAMP-mediated signaling in Fmr1 KO neurons and demonstrate that pharmacological manipulations increasing cAMP levels can rescue synaptic morphology and function, learning, and behavior in animal models of FXS.